Giorgia Mangili - Concepedia

Author

Giorgia Mangili

Vita-Salute San Raffaele University ORCID

Also Known As

Cristina Sigismondi, G Mangili, G. MANGILI, G. MangilI, G. Mangili, GIORGIA MANGILI, Giorgia Mangili, Giorgio Valabrega, Monica Fumagalli, P. De Marzi

324

Publications

10.3K

Citations

H-Index

114

Concepts

All Affiliations

Vita-Salute San Raffaele University Istituti di Ricovero e Cura a Carattere Scientifico San Raffaele University of Rome Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele University of Milan

About

Giorgia Mangili is an author at Vita-Salute San Raffaele University specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	65	3.2K
2	Public Health	14	14	657
3	Health Sciences	10	10	574
4	Biostatistics	1	1	34
5	Cell Biology	1	1	29

Giorgia Mangili

113

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, New England Journal of Medicine	2019	2.1K
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial Pierluigi Benedetti Panici, S. Basile, F. Maneschi, JNCI Journal of the National Cancer Institute	2008	1.5K
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, The Lancet OncologyCervical CancerMetronomic TherapyPathologyRecurrent Cervical Cancer	2023	175
Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P) Giorgio Bolis, Nicoletta Colombo, S. Pecorelli, Annals of Oncology MedicineChromic PhosphateRandomised Clinical TrialsGynecologyAdjuvant Treatment	1995	173
Integrated FDG PET/CT in Patients with Persistent Ovarian Cancer: Correlation with Histologic Findings Sandro Sironi, Cristina Messa, Giorgia Mangili, Radiology	2004	171
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary Giorgia Mangili, Jessica Ottolina, Angiolo Gadducci, British Journal of Cancer	2013	163
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases Mauro Signorelli, Luca Guerra, Alessandro Buda, Gynecologic Oncology Positron Emission TomographySurgical OncologyGynecological SurgeryHealth SciencesMedical Imaging	2009	122
Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors Giorgia Mangili, Cristina Sigismondi, Angiolo Gadducci, International Journal of Gynecological Cancer	2011	113
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer Giorgia Mangili, Maria Picchio, Sandro Sironi, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyHealth SciencesOncologic ImagingMedicineCancer Recurrence	2006	104
Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study Cristina Sigismondi, Angiolo Gadducci, Domenica Lorusso, Gynecologic Oncology Tumoral PathologyFemale InfertilityReproductive HealthPathologyGynecology	2012	101

Page 1